US Bancorp
ARKG icon

US Bancorp’s ARK Genomic Revolution ETF ARKG Stock Holding History

US Bancorp’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Sell
686
-157
-19% -$5K ﹤0.01% 3044
2026
Q1 		$22.3K Sell
843
-100
-11% -$2.93K ﹤0.01% 3049
2025
Q4 		$27.3K Sell
943
-394
-29% -$11.8K ﹤0.01% 2951
2025
Q3 		$37.1K Sell
1,337
-2,961
-69% -$74.8K ﹤0.01% 2801
2025
Q2 		$105K Buy
4,298
+218
+5% +$4.78K ﹤0.01% 2399
2025
Q1 		$84.7K Sell
4,080
-1,630
-29% -$41K ﹤0.01% 2466
2024
Q4 		$134K Sell
5,710
-921
-14% -$22.7K ﹤0.01% 2244
2024
Q3 		$170K Sell
6,631
-1,278
-16% -$32.5K ﹤0.01% 2115
2024
Q2 		$186K Buy
7,909
+790
+11% +$19.9K ﹤0.01% 2043
2024
Q1 		$205K Buy
7,119
+620
+10% +$18.6K ﹤0.01% 1999
2023
Q4 		$213K Buy
6,499
+6,380
+5,361% +$173K ﹤0.01% 1976
2023
Q3 		$3.31K Hold
119
– – ﹤0.01% 3550
2023
Q2 		$4.06K Sell
119
-570
-83% -$17.9K ﹤0.01% 3535
2023
Q1 		$20.7K Sell
689
-798
-54% -$24.7K ﹤0.01% 2969
2022
Q4 		$42K Sell
1,487
-200
-12% -$6.35K ﹤0.01% 2628
2022
Q3 		$55K Buy
1,687
+200
+13% +$7.34K ﹤0.01% 2473
2022
Q2 		$47K Hold
1,487
– – ﹤0.01% 2620
2022
Q1 		$68K Buy
1,487
+110
+8% +$5.24K ﹤0.01% 2458
2021
Q4 		$84K Sell
1,377
-3,310
-71% -$229K ﹤0.01% 2381
2021
Q3 		$350K Sell
4,687
-115
-2% -$9.65K ﹤0.01% 1694
2021
Q2 		$444K Sell
4,802
-300
-6% -$25.5K ﹤0.01% 1608
2021
Q1 		$453K Buy
5,102
+2,838
+125% +$282K ﹤0.01% 1555
2020
Q4 		$211K Buy
+2,264
New +$180K ﹤0.01% 1849

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

US Bancorp's ARKG Position: Q2 2026 in Review

US Bancorp reduced its ARK Genomic Revolution ETF (ARKG) stake by 19% in Q2 2026, selling an estimated $5K and leaving 686 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

US Bancorp first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $453K in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • US Bancorp held 686 shares of ARK Genomic Revolution ETF worth $28.9K as of Q2 2026.
  • US Bancorp sold 157 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3044 holding.
  • US Bancorp first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • US Bancorp's ARK Genomic Revolution ETF position peaked at $453K in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.